Since NSCLC patients have been shown to have an abnormal Th-2-type cytokine pattern [30] which negatively impacts immunotherapy [31], we believe the ability of CTA-loaded DCs to stimulate Th-1 polarization effect may be clinically relevant [32]. This evidence concerns the gene NELFCD and non-small cell lung carcinoma.